CAMBIUM NETWORKS CORP (CMBM)

KYG177661090 - Common Stock

0.868  +0.08 (+10.71%)

After market: 0.8916 +0.02 (+2.72%)

Fundamental Rating

2

Overall CMBM gets a fundamental rating of 2 out of 10. We evaluated CMBM against 51 industry peers in the Communications Equipment industry. While CMBM seems to be doing ok healthwise, there are quite some concerns on its profitability. CMBM does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

CMBM had negative earnings in the past year.
CMBM had a negative operating cash flow in the past year.
In multiple years CMBM reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CMBM reported negative operating cash flow in multiple years.

1.2 Ratios

CMBM has a worse Return On Assets (-44.08%) than 86.27% of its industry peers.
Looking at the Return On Equity, with a value of -224.89%, CMBM is doing worse than 88.24% of the companies in the same industry.
Industry RankSector Rank
ROA -44.08%
ROE -224.89%
ROIC N/A
ROA(3y)-3.98%
ROA(5y)-2.62%
ROE(3y)-16.13%
ROE(5y)-12.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 17.14%, CMBM is not doing good in the industry: 94.12% of the companies in the same industry are doing better.
CMBM's Gross Margin has declined in the last couple of years.
CMBM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y-8.13%

More info and screens

4

2. Health

2.1 Basic Checks

CMBM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CMBM has more shares outstanding
The number of shares outstanding for CMBM has been increased compared to 5 years ago.
The debt/assets ratio for CMBM is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.96, we must say that CMBM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.96, CMBM is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
CMBM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.96
ROIC/WACCN/A
WACC9.68%

2.3 Liquidity

A Current Ratio of 1.10 indicates that CMBM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.10, CMBM is doing worse than 84.31% of the companies in the same industry.
CMBM has a Quick Ratio of 1.10. This is a bad value and indicates that CMBM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.82, CMBM is doing worse than 84.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.82

More info and screens

3

3. Growth

3.1 Past

CMBM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1047.37%.
Looking at the last year, CMBM shows a very negative growth in Revenue. The Revenue has decreased by -34.89% in the last year.
Measured over the past years, CMBM shows a decrease in Revenue. The Revenue has been decreasing by -1.85% on average per year.
EPS 1Y (TTM)-1047.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.18%
Revenue 1Y (TTM)-34.89%
Revenue growth 3Y-7.53%
Revenue growth 5Y-1.85%
Sales Q2Q%1.58%

3.2 Future

The Earnings Per Share is expected to grow by 22.05% on average over the next years. This is a very strong growth
CMBM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.03% yearly.
EPS Next Y10.02%
EPS Next 2Y36.71%
EPS Next 3Y22.05%
EPS Next 5YN/A
Revenue Next Year-20.91%
Revenue Next 2Y-4.01%
Revenue Next 3Y0.03%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMBM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMBM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CMBM's earnings are expected to grow with 22.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.71%
EPS Next 3Y22.05%

More info and screens

0

5. Dividend

5.1 Amount

CMBM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAMBIUM NETWORKS CORP

NASDAQ:CMBM (1/3/2025, 8:00:01 PM)

After market: 0.8916 +0.02 (+2.72%)

0.868

+0.08 (+10.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-13 2025-02-13/amc
Inst Owners33.76%
Inst Owner Change-5.76%
Ins Owners4.06%
Ins Owner Change3.04%
Market Cap24.51M
Analysts80
Price Target3.4 (291.71%)
Short Float %5.35%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.63%
Min EPS beat(2)-15.61%
Max EPS beat(2)18.88%
EPS beat(4)1
Avg EPS beat(4)-57.09%
Min EPS beat(4)-139.74%
Max EPS beat(4)18.88%
EPS beat(8)3
Avg EPS beat(8)-82.13%
EPS beat(12)7
Avg EPS beat(12)3.73%
EPS beat(16)11
Avg EPS beat(16)9.26%
Revenue beat(2)0
Avg Revenue beat(2)-3.75%
Min Revenue beat(2)-5.39%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-5.07%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-2.12%
Revenue beat(8)1
Avg Revenue beat(8)-5.94%
Revenue beat(12)3
Avg Revenue beat(12)-3.54%
Revenue beat(16)6
Avg Revenue beat(16)-2.28%
PT rev (1m)0%
PT rev (3m)-22.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-269.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-36.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 1.77
EV/EBITDA N/A
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS6.1
BVpS1.54
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.08%
ROE -224.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.14%
FCFM N/A
ROA(3y)-3.98%
ROA(5y)-2.62%
ROE(3y)-16.13%
ROE(5y)-12.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y-8.13%
F-Score2
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 128.96%
Cap/Sales 7.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.82
Altman-Z -0.96
F-Score2
WACC9.68%
ROIC/WACCN/A
Cap/Depr(3y)130.65%
Cap/Depr(5y)120.32%
Cap/Sales(3y)3.75%
Cap/Sales(5y)3.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1047.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.18%
EPS Next Y10.02%
EPS Next 2Y36.71%
EPS Next 3Y22.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.89%
Revenue growth 3Y-7.53%
Revenue growth 5Y-1.85%
Sales Q2Q%1.58%
Revenue Next Year-20.91%
Revenue Next 2Y-4.01%
Revenue Next 3Y0.03%
Revenue Next 5YN/A
EBIT growth 1Y-733.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-56.73%
EBIT Next 3Y65.62%
EBIT Next 5YN/A
FCF growth 1Y-105.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-595.46%
OCF growth 3YN/A
OCF growth 5YN/A